We studied the expression of arachidonate 5-lipoxygenase (5-LO) in a cell line of human keratinocytes (HaCaT) and in normal human skin keratinocytes in tissue culture. In undifferentiated keratinocytes 5-LO gene expression was low or undetectable as determined by 5-LO mRNA, protein, cell-free enzyme activity, and leukotriene production in intact cells. However, after shift to culture conditions that promote conversion of prokeratinocytes into a more differentiated phenotype, 5-LO gene expression was markedly induced in HaCaT cells and, to a lesser extent, in normal keratinocytes. These results show that 5-LO gene expression is an intrinsic property of human skin keratinocytes.
morphonuclear neutrophils the enzyme was identified in other leukocyte lineages (1, 2) . Products of the 5-LO pathway, including leukotriene (LT) B4 and the cysteinyl LTs, in addition to their roles as inflammatory agonists, may act as physiological autocrine or paracrine signaling molecules. Until recently 5-LO expression was thought to be restricted to the hematopoietic system. However, attempts to identify the enzyme in other tissues yielded results that support the hypothesis that it is expressed in distinctive extrahematopoietic epithelia. Thus, Natsui et al. (3) provided evidence that 5-LO protein is present in the nuclear envelope of porcine pancreatic acinar cells, and the studies of Sjolander et al. (4) and Dias et al. (5) indicated the formation of 5-hydro(pero)xyeicosatetraenoic acid [5-H(P)ETE] and LTB4 in cultured human Henle intestine 407 cells and human colon CaCo-2 cells, respectively. Expression of the 5-LO pathway in skin epithelium likewise remains debatable. Several authors using primary skin keratinocytes reported the production of 5-hydroxyeicosatetraenoic acid (5-HETE) and LTB4, but subsequent work challenged some of the earlier interpretations (refs. 6-11; for review, see ref. 12) .
We have used a nontransformed human keratinocyte cell line, HaCaT, and normal human skin keratinocytes (NHKs) as in vitro models to study expression of the 5-LO pathway in extrahematopoietic epithelia. HaCaT cells are derived from a normal skin biopsy and maintain a substantial differentiation potential in culture (13, 14) . In this report we show that the 5-LO gene is expressed in both HaCaT cells and NHKs under conditions that favor their differentiation. (16) (17) (18) . The ratio of 5-LO/GAPDH mRNA determined by densitometry of autoradiograms from 4d cells was defined as 1 on each filter.
MATERIALS AND METHODS
Reverse transcription-PCR (RT-PCR). Procedures and primers were as described (19) . Six 
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shorter as compared with the 5-LO cDNA. For determining the amounts of GAPDH PCR transcripts, a GAPDH internal standard was used that yielded a PCR product that was 100 bp shorter than that derived from GAPDH cDNA.
Immunoblots. One hundred and fifty micrograms of total homogenate protein per lane was separated on SDS/7.5% polyacrylamide gels and transferred onto Hybond-C Super membranes (Amersham). Rabbit polyclonal antisera were generated against an Escherichia coli-expressed human 5-LOtrpE fusion protein (see Fig. 2A) or an E. coli-expressed human 5-LO protein (see Fig. 2B ), affinity-purified by using recombinant human 5-LO, and used at a dilution of 1:1000, followed by enhanced chemiluminescence (ECL) detection (Amersham).
5-LO activity assay. Cells (5 x 107) were homogenized in 0.5 ml of homogenization buffer as described (20, 21 ) with a Branson model W450 sonifier (power setting 3.5) for 10 sec on ice. Protein was determined according to Bradford (22) ,tM AA at 37°C as described (20, 21 (20) , and determination of 5-HETE peak areas were done as described after adding 1 nmol of prostaglandin (PG)B2 (20, 21) .
Quantitation of LT formation in intact cells by HPLC and RL4. After removal of culture medium and addition of 6 was an up to 30-fold induction of 5-LO mRNA relative to GAPDH or f3-actin mRNA during a 70d differentiation program ( Fig. 1 ; additional data not shown). The induction of 5-LO mRNA was most apparent between 4d and 13d (during which time the cells reached confluency) and continued to rise thereafter. The increase in 5-LO mRNA was also seen by RT-PCR using primers previously used for leukocyte RT-PCR analyses (19) ; to quantify the PCR products, 5-LO internal standards were used in the PCR step. Assuming equal efficiencies in the reverse transcriptions, there were up to 32-fold increases in 5-LO transcript levels when PCR products are expressed per total RNA or per GAPDH or ,B-actin transcripts; kinetics resembled those obtained in Northern blots ( Fig. 1 ; Table 1 ; data not shown).
To explore the possibility that the 5-LO gene can be expressed in NHKs, human foreskin keratinocytes were expanded in serum-free KGM. These culture conditions were chosen to eliminate contaminating Langerhans cells, melanocytes, and fibroblasts (that do not proliferate in low Ca2+ medium) from the initial epidermal cell preparation (26, 27) . Although 5-LO transcripts were undetectable in passage-3 (14, 26, 27) . Nevertheless, the PCR data show that NHKs maintained in KGM for three passages respond toward differentiation factors in FCS by up-regulating expression of the 5-LO gene. 5-LO transcripts were also found in normal adult trunk skin keratinocytes maintained on irradiated fibroblast feeder layers.
5-LO Protein Induction in HaCaT Keratinocytes and NHKs. Immunoblot analyses of HaCaT cells revealed induction of a 78-kDa protein during a 44d differentiation program, which roughly paralleled induction of 5-LO transcripts ( Fig.   2A ). The induced protein comigrated with 5-LO of RBL1 cells or with 5-LO purified from human leukocytes (data not shown). Expression of the 78-kDa protein was detectable between 4d and 12d, and further induction was seen thereafter. Antiserum preabsorbed with recombinant leukocyte 5-LO was unable to recognize the induced 78-kDa species, whereas an affinity-purified antibody did so ( Fig. 2A ; additional data not shown). The induced 78-kDa protein was also recognized by two additional independent affinity-purified rabbit polyclonal 5-LO antisera directed against recombinant 5-LO and by a rabbit polyclonal anti 5-LO antibody directed against native human leukocyte 5-LO (data not shown). Similar results were obtained in analyses of NHKs (Fig. 2B) . Analogous to 5-LO transcripts, the relative amount of 5-LO protein in NHKs was significantly lower than in HaCaT keratinocytes under standard differentiation conditions. In view of the stronger inducibility of the 5-LO gene in HaCaT cells under standard A differentiation conditions, the experiments described below were done with HaCaT cells.
5-LO Activity in Cell-Free Systems of Undifferentiated and Differentiated HaCaT Keratinocytes. 5-LO activity was determined by using HaCaT cell homogenates or 105 x g supernatants. Formation of 5-HETE was low in 4d cells. However, differentiated cells acquired a major 5-HETE-producing activity ( Fig. 3 ; Table 2 ) as shown by coelution of the major AA metabolite with 5-HETE standards on two reverse-phase and one straight-phase HPLC system. 5-LO specific activity, as determined by 5-HETE peak area, was stimulated by a factor of 27 on d20 ( Table 2 , assay A) and continued to rise thereafter ( Table 2 , assay B). Significant amounts of nonenzymatic LTA4 hydrolysis products (6-trans-LTB4, 6-trans-12-epi-LTB4, and a pair of 5,6-diHETE isomers) were also formed in cell-free systems of differentiating HaCaT keratinocytes (Fig. 3A) , whereas they were undetectable in the same assays of 4d cells. One micromolar L-656,224, a direct 5-LO inhibitor (20) , completely prevented formation of all 5-LO products (data not shown). By contrast, HaCaT cells induced to differentiate in response to DMEM/FCS after maintenance in KGM showed low 5-LO activity (data not shown).
5-LO metabolites formed in nine independent experiments with HaCaT homogenates were quantitated by GC/NICI-MS. -(16 were quantitated by GC/NICI-MS as described (compare with Fig. 4 ).
ND, not determined.
After 40d to 50d differentiation the capacity to produce 5-HETE and LTB4 had increased to 100-fold ( Fig. 4 ; Table 2 GC/NICI-MS).
We next determined the stereochemistry of the putative 5-LO enzyme reaction. For this purpose, homogenates prepared from differentiating HaCaT Fig. 3B) . In a parallel identical incubation using unlabeled AA the total yield of 5-HETE was 0.82 ,ug as determined by GC/NICI-MS, corresponding to 6.7% of exogenous substrate (23) .
Intact Differentiated HaCaT Keratinocytes Produce LTB4 and LTC4. We considered the possibility that HaCaT keratinocytes can express the entire 5-LO pathway to produce LTs.
HaCaT cell lipids were prelabeled with [14C]AA, and LT production was initiated by adding Ca2+ ionophore. Two radiolabeled peaks that comigrated with unlabeled standard LTB4 and LTC4 were observed upon HPLC separation. One micromolar MK-886, which has previously been shown to bind to the 5-LO activating protein (28) , blocked formation of radiolabeled LTs (Fig. 5) . Additional evidence for the ability of HaCaT keratinocytes to produce both LTB4 and LTC4 was obtained in similar experiments with unlabeled AA. Peaks corresponding to retention times of LTB4 and LTC4 in HPLC were analyzed by RIA in four experiments. There was a potent up-regulation of both LTB4 and LTC4 immunoreactivities during HaCaT keratinocyte differentiation (Table 3) , which was sensitive to 1 ,uM MK-886 (data not shown). (30) . Our data also indicate that HaCaT keratinocytes can produce LTC4.
Elevated levels of unesterified AA, 5-HETE, 12-HETE, and LT immunoreactivities have been found both in the skin and in the circulation of patients afflicted with inflammatory skin diseases (6, 7, 9, 11, 31) . The initial triggers of most of these diseases largely remain to be identified, but proinflammatory agonists including LTs have been implicated in disease progression (9) . Several inflammatory skin diseases are characterized by epidermal infiltration of leukocytes of various lineages, some of which produce LTs (9) . Most investigators (7, 8, 10, 12, 29, 30) have therefore assumed that epidermal LTs are derived from leukocytes that have been recruited into the skin, or that have been produced after export of leukocytederived LTA4 and subsequent metabolism by keratinocytes. Although these assumptions remain viable, the ability of cultured keratinocytes to express the 5-LO gene raises the possibility that the keratinocyte 5-LO pathway plays a primary role in skin biology. In this regard it is of interest that LTB4 can affect keratinocyte proliferation (7) and that LTC4 enhances migration and the differentiated phenotype of cultured melanocytes (32, 33) . However, the molecular basis for the relation between proliferation, differentiation, and expression of the 5-LO gene in keratinocytes remains elusive.
It has been recognized that normal epidermal morphogenesis and differentiation require keratinocyte/mesenchymal interactions to generate keratinocyte differentiation factors, but the precise nature of the mesenchymal-derived signals remains poorly understood (14) . Although serum-free culture systems yield populations of pure prokeratinocytes (26, 27) , they do not mimic completely the epidermal microenvironment in vivo (14) . In addition to the culture systems used here, in vivo keratinocyte differentiation models should prove useful to further delineate the regulation of 5-LO gene expression in keratinocytes.
